The glial cell specificity of the human papovavirus JC (JCV), an etiologic agent for progressive multifocal leukoencephalopathy, is thought to be due to the presence of both positive and negative regulatory elements upstream of the TATA region within the JCV promoter. Here we report that the JCV minimal core promoter, containing only the TATA box and an 8-bp poly(T) region immediately upstream, is sufficient to initiate transcription of an attached gene in glial cells and functions as an autonomously active initiator. We further define the sequences required for this core promoter's glial cell specificity by appropriate substitution and point mutation analysis. Ectopic expression of Tst-1, a POU domain transcription factor that has been implicated in the regulation of oligodendrocyte development, leads to higher activation of the JCV minimal core promoter in Tst-1-deficient glial cells than in non-glial HeLa cells. These results suggest a requirement for a glial cell coactivator(s) for the optimum activation of the JCV minimal core promoter by Tst-1. A discrete affinity of Tst-1 for the JCV core promoter (K d , 1.4 ؋ 10 ؊8 M) is also shown to be optimal for its promoter strength. Mutations within the core promoter that maintain this affinity for Tst-1 show maintenance of promoter strength, whereas mutants carrying a change that results in an increased affinity for Tst-1 show reduced transcriptional activity. These results suggest that moderate affinity of Tst-1 for the JCV TATA region may allow the interaction of some glial cell-specific coactivator(s) along with the basal transcription machinery to direct glial cell-specific transcription from the JCV core promoter.
The papovavirus JC (JCV), a widely prevalent human DNA tumor virus, is the etiological agent of a fatal demyelinating disorder of the central nervous system called progressive multifocal leukoencephalopathy (PML) (for reviews, see references 11, 25, and 39). Many patients with PML also develop systemic tumors, and in hamsters, the inoculation of JCV causes glioblastomas and medulloblastomas (11, 25) . These pathological aspects of JCV are believed to be due, at least in part, to the transcriptionally restricted expression of the viral early genes in glial cells. Cell type-specific transcription as well as viral DNA replication is regulated by an approximately 300-bp noncoding region of the JCV genome (11, 25, 39) .
Many cis-acting promoter elements within the noncoding region have been shown to provide both positive and negative controls in the regulation of JCV transcription (1-3, 9, 11, 13, 16, 17, 19, 21-23, 25, 32-36, 40) . DNA-binding proteins that interact with these cis elements have also been identified in glial and nonglial cells. These include nuclear factor-1 (NF-1) and NF-1-like proteins (23) , a 45-kDa brain-specific protein (GF-1) (17), a 70-to 80-kDa glial protein that interacts with the AGGGA domain in the presence of neighboring cis elements (21, 22) , a 53-to 56-kDa protein present in both glial and nonglial cells that binds to the AGGGA domains in the absence of neighboring cis elements (33, 35) , and a 52-kDa single-stranded-DNA-binding protein that also interacts with the AGGGA domains of the late strand of JCV (34) . In addition, a POU domain transcription factor, Tst-1 (also called SCIP and Oct-6), has been shown to activate transcription from the JCV early and late promoters when ectopically expressed in non-Tst-1-expressing glial cells (40) . In spite of these efforts, it remains unclear how these cis-and trans-acting factors interact with one another to confer glial cell-specific transcription on the JCV promoter.
However, it has been hypothesized that the regulatory region of nonpathogenic archetype variants of JCV undergo frequent alterations in vivo, leading to a variety of pathogenic variants which exhibit altered host range and oncogenic properties (11, 15, 24, 26, 41) . Sequence comparisons of the regulatory regions of the archetypal and PML-associated variants suggest the importance of short DNA segments (from 23 to 66 bp) that may contain essential cis elements involved in determining cell type specificity (4, 15, 41) .
As part of the general strategy to define the role of various cis elements within the JCV regulatory region, we created a series of deletion mutant-chloramphenicol acetyltransferase (CAT) constructs from several variants of JCV and evaluated their transcriptional properties in both glial and non-glial cells. In this report, we provide evidence that the JCV minimal core promoter, a 28-bp TATA region from nucleotide (nt) 1 to nt 28 (10) that remains unaltered in all JCV variants, is able to support the glial cell-specific transcription of a reporter gene without the aid of upstream cis elements (6) . We demonstrate that the interaction of Tst-1 with the JCV minimal core promoter is sequence dependent. Moreover, the binding of Tst-1 to this region is such that alterations to the sequence that increase or decrease the affinity for Tst-1 reduce the transcriptional activity of this truncated promoter. Furthermore, optimal transactivation of the JCV promoter by Tst-1 may require an additional glial cell-specific cofactor(s).
MATERIALS AND METHODS
Materials. pM11.3Cat (11) , the source for the JCV (Mad11.3) regulatory region, and pMAD-1 BR (26) , the source for the JCV (Mad1) regulatory region, were kindly provided by R. J. Frisque. Expression plasmid pCMV-Tst-1 and the recombinant glutathione-S-transferase-Tst-1 (Gst-Tst-1) fusion protein were kindly provided by M. G. Rosenfeld. Synthesis of oligonucleotides and the sequencing of various CAT constructs were carried out by the DNA Synthesis and Sequencing Facilities at Wayne State University.
Plasmid constructs. p11.3.0E was constructed by cloning the 280-bp HindIII fragment of pM11.3Cat (11) into the HindIII site of pGK0Cat (20) . The designation E indicates that the CAT gene is in the position of the viral early genes relative to the JCV regulatory region. pJCV1 E Cat was constructed by cloning the 288-bp HindIII-PvuII fragment of pMAD-1 BR (26) into the HindIII and SmaI sites in pGK0Cat (20) . p11.3.5E, p11.3.6E, p1.5E, p11.3.8E, p11.3.11E, p11.3.12E, and p11.3.13E were synthesized by cloning annealed oligomers (see Fig. 3 ) into the SmaI site of pGK0Cat.
Cell cultures and transfections. The cell lines human glioblastoma U87-MG, human cervical carcinoma HeLa, human fibrosarcoma HT1080, green monkey kidney CV-1, human glioblastoma U138-MG, and rat glioma C6 were purchased from the American Type Culture Collection. All cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. Cells were transfected by the calcium phosphate precipitation method (5) . Briefly, 20 g of DNA per 100-mm 2 dish was precipitated onto 5 ϫ 10 5 to 8 ϫ 10 5 cells in monolayer for a period of 6 to 16 h. Cells were shocked with 15% glycerol in a HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid)-buffered saline solution, pH 7.12, for 3 min at room temperature. Cells were harvested 48 h after the glycerol shock, and a crude cell extract was prepared by repeated freeze-thawing. Equal amounts of protein were assayed for CAT activity in a 2-h reaction by published protocols (5) . Percent conversion of nonacetylated to acetylated [ 14 C]chloramphenicol was determined by PhosphorImager (Molecular Dynamics) and/or by liquid scintillation counting of acetylated and nonacetylated [
14 C]chloramphenicol. CAT activity was normalized to transfection efficiency, as determined by pSV␤Gal (Promega) cotransfection and subsequent ␤-galactosidase assay and/or by Hirt (14) preparation of transfected DNA and quantitation by slot blot hybridization with a 32 P-labeled CAT probe. Primer extension analysis. Total RNA from U87-MG cells transfected with pGK0Cat, pJCV1 E Cat, and p11.3.5E was isolated by the hot phenol method (31) . The primer T7CATFTP-R (5Ј-CTCCTGAAAATCTCGCCAAG-3Ј), complementary to sequence immediately upstream from the initiation codon of the CAT gene, was end labeled with [␥-32 P]ATP and T4 polynucleotide kinase. The primer extension reaction was completed with avian myeloblastosis virus reverse transcriptase according to published protocols (5) . The products of the reaction were run on a 9% denaturing polyacrylamide gel adjacent to sequencing reaction products, which were used to determine primer extension product size and initiation site. Sequencing was performed according to instructions for the Circumvent Thermal Cycle Dideoxy DNA sequencing kit (New England Biolabs).
EMSA. To generate the radioactive JCV TATA probe, representing the wildtype JCV minimal core promoter, oligonucleotide AK-4R (see Fig. 3 ) was end labeled with [␥- 32 P]ATP and T4 polynucleotide kinase. One picomole of endlabeled AK-4R was annealed to unlabeled complementary oligonucleotide AK-4F (see Fig. 3 ) in 1ϫ SSC (0.15 M NaCl plus 0.015 M sodium citrate). The complementary oligonucleotides were heated to 90ЊC for 5 min and then allowed to cool to 60ЊC over a period of 2 h and finally to room temperature overnight. The efficiency of duplex formation was determined by analysis on nondenaturing 15% polyacrylamide gels. The unlabeled competitor duplexes representing mutant JCV core promoters and the simian virus 40 (SV40) core promoters were similarly generated by annealing complementary oligonucleotides (see Fig. 3 ). For the electrophoretic mobility shift assays (EMSAs), 5.0 fmol of labeled probe was incubated for 30 min at 30ЊC with 20 ng of recombinant Gst-Tst-1 fusion protein in a 20-l reaction mixture containing 20 mM HEPES-KOH (pH 7.9), 10% glycerol, 15 mM KCl, 2 mM spermidine, 0.1 mM EDTA, 0.5 mM dithiothreitol, 100 g of bovine serum albumin per ml, 100 ng of poly(dI-dC), and 0.025% Nonidet P-40. For competition analysis, the competitors were added simultaneously with the probe. The reaction mixtures were analyzed on a nondenaturing 7% polyacrylamide gel. Electrophoresis was done in 0.5ϫ TBE (Trisborate-EDTA) at 200 V for 2 h at 4ЊC. Quantitation of the bound and free probe was performed with the PhosphorImager (Molecular Dynamics) and subsequently analyzed with the Microsoft Excel version 4.0 program.
RESULTS
JCV early minimal core promoter is transcriptionally active and glial cell specific. In order to determine the transcriptioncontrolling mechanisms of the PML-associated variants of JCV (e.g., Mad1 and Mad11.3), a series of early promoter deletion mutants were created (6) . The deletions were designed so that putative cis elements were sequentially removed from the 5Ј ends of the JCV early promoters and cloned upstream of a CAT gene in the plasmid pGK0Cat. Plasmids pJCV1 E Cat and p11.3.0E contain the full-length early promoter regions of JCV Mad1 and Mad11.3, respectively (Fig. 1A) . These regulatory regions consist of 280 bp and are numbered according to Frisque et al. (10) . Potentially important cis elements found within these promoter regions include consensus binding sites for the transcription factors NF-1 and Sp1 as well as putative TATA boxes (Fig. 1A) . The construct p11.3.5E represents the most truncated regulatory region in this deletion mutation series and contains only a TATA box and an immediately adjacent poly(T) stretch. The nucleotide sequence of this 28-bp stretch is conserved among all JCV variants. Transient transfection of this highly truncated promoter construct into the human glioblastoma cell line U87-MG (Fig. 1B) and the rat glioma cell line C6 (see Fig. 4B ) revealed that approximately 50% of the activity of the full-length promoter was retained. Thus, we have defined this 28-bp region as the JCV early minimal core promoter.
To determine if the JCV minimal core promoter is also glial cell specific, we transfected both full-length wild-type promoter constructs (pJCV1 E Cat and p11.3.0E) and p11.3.5E into glial U87-MG cells and several nonglial cell lines. The results of the CAT assays, displayed as percent conversion of [
14 C]chloramphenicol to acetylated forms, are graphed in Fig. 1B . To compare the results from different cell types, the percent conversion obtained for all the constructs was normalized to a 1% conversion value for the promoterless construct pGK0Cat. In glial cells, the activities for pJCV1 E Cat, p11.3.0E, and p11.3.5E were ϳ20, ϳ15, and ϳ7.8%, respectively. These values are substantially higher than the ϳ1.2 to 3.4% observed for these constructs in other cell types. A striking exception was noted when p11.3.0E was transfected into cells of epithelial origin; the activities were 6.9% in HeLa and 6.6% in HT1080 cells. This level of activity in nonglial epithelial cells for the Mad11.3 promoter may reflect an arrangement of cis elements upstream from the minimal core promoter that reduces the tight cell type specificity within this variant. Nevertheless, the results shown in Fig. 1 indicate that the early minimal core promoter maintains both transcriptional activity and glial cell specificity.
Transcriptional initiation by JCV minimal core promoter. Primer extension analysis was performed as described in Materials and Methods on RNA purified from U87-MG cells transfected with plasmids pJCV1 E Cat and p11.3.5E to determine the sites of transcription initiation for these promoters in glial cells. The full-length JCV (Mad1) early promoter directs transcription from a single site approximately 40 bp downstream from the center of the TATA region, as observed by Daniel and Frisque (7); the JCV minimal core promoter, p11.3.5E, initiates transcription from four different locations (Fig. 2) . The most prominent start site is located within the poly(T) stretch about 8 bp upstream of the TATA box, and other start sites are located 5, 25, and 40 bp downstream from the TATA box (Fig. 2 ). This suggests that the JCV minimal core promoter, in the absence of upstream elements, functions as an initiator, in that transcription initiates from multiple sites within the sequence rather than from the usual location approximately 30 to 40 bp downstream from the TATA box.
Mutational analysis of the JCV minimal core promoter. To determine how the transcriptional activity of the JCV minimal core promoter is dependent on its nucleotide sequence, a series of substitution and point mutation CAT constructs were created. The oligonucleotides shown in Fig. 3 were annealed and cloned into pGK0Cat upstream of the CAT reporter gene. Constructs p1.5E and p11.3.6E (Fig. 4A ) contain substitution mutations downstream and upstream from the TATA region, respectively, and were used to assess the contribution of the sequence flanking the TATA region. Construct p11.3.8E contains the region of the SV40 promoter which is analogous to the JCV minimal core promoter. There are only three nucleotide positions within p11.3.8E that differ from the wild-type JCV sequence present in p11.3.5E. These divergent positions Each divergent nucleotide position of p11.3.8E was altered independently so that it resembled the sequence found in JCV (p11.3.5E). Relative to the SV40 sequence (p11.3.8E), construct p11.3.11E contains an additional GC base pair at nt 11, p11.3.12E contains a GC3AT transition at nt 15, and p11.3.13E contains a TA3AT transition at nt 19 ( Fig. 3 and  4A ).
These constructs were transiently transfected into C6 glial cells, and the subsequent CAT assay percent conversion data were compared with those obtained with p11.3.5E, which is shown as 100% in Fig. 4B . Comparison of the full-length Mad11.3 promoter (p11.3.0E) with the minimal core promoter in p11.3.5E again indicates that ϳ50% of the activity from the full-length promoter is retained. Similar results were observed with the human glioblastoma cell line U87-MG (Fig. 1B) . Constructs p1.5E and p11.3.6E showed 4.6 and 22.3% relative activity, respectively. This analysis revealed that the JCV wildtype core promoter (p11.3.5E) had significantly more activity than either of the plasmids containing mutations flanking the TATA region (p11.3.6E and p1.5E) (Fig. 4B) . Mutations downstream from the TATA box inhibited transcription more than did those in the poly(T) stretch. Thus, transcription from the JCV minimal core promoter depends on the sequence that surrounds the TATA region.
To determine the precise nucleotides involved in this sequence dependency, we compared the wild-type JCV sequence with the analogous region in the related polyomavirus SV40. Within the analogous regions of these two viruses, there appear to be only three nucleotide positions that are not identical (Fig. 4A, compare p11 .3.5E with p11.3.8E). Transfection of p11.3.8E into C6 cells resulted in less than 1% of the transcriptional activity of the wild-type JCV construct p11.3.5E, as shown in Fig. 4B . This indicates that the nucleotides that differ between the SV40 sequence and the JCV sequence are absolutely critical for transcription from the JCV minimal core promoter in glial cells.
In order to define the role of each divergent position independently, we transfected constructs p11.3.11E, p11.3.12E, and p11.3.13E into C6 cells. The relative activities were ϳ108, ϳ38, and ϳ1.2%, respectively (Fig. 4B) . Remarkably, the insertion of a GC base pair at position 11 (Fig. 4A, p11. 3.11E), slightly downstream of the canonical SV40 TATA, restored 100% of the activity observed for the wild-type JCV sequence. A CG3AT transition at position 15 (p11.3.12E) restored only partial promoter activity, and an AT3TA transition at position 19 (p11.3.13E) had no effect (Fig. 4B) . From these findings, we have identified two sites within the JCV core promoter that affect transcription: a single GC base pair at position 11 that is essential for activity and an AT base pair at position 15 with partial influence.
These two nucleotide positions are present within the binding site for the POU domain transcription factor Tst-1 (40) (Fig. 4A) . In order to determine if Tst-1 is responsible for the expression pattern from the mutant JCV core promoters shown in Fig. 4B , we co-transfected this series along with the expression construct pCMV-Tst-1 into nonglial HeLa cells. The observed pattern of expression in the presence of exogenous Tst-1 was similar to that seen in glial cells (see Fig. 6D ), indicating that Tst-1 is intimately involved in determining the transcriptional activity from these mutant promoters.
Optimal Tst-1 transactivation requires upstream cis elements and a glial cell-specific cofactor. Two superimposed protein-binding domains, the canonical TATA, which is generally associated with the binding of TFIID in the basal transcriptional machinery, and a region recognized by the POU domain transcription factor Tst-1, are present in the JCV minimal core promoter (Fig. 4A) . Since TFIID is involved with ubiquitous basal transcription and JCV transcription is highest in glial cells, we were interested in defining the transactivation mechanism used by the glial cell-specific factor Tst-1.
Previously, Tst-1 has been shown to transactivate the JCV (Mad1) early promoter through its interaction with the sequence surrounding the TATA box (40) . Here, we asked if cis elements upstream from the TATA region influence Tst-1 transactivation and if this influence is glial cell specific. To answer these questions, we cotransfected the expression plasmid pCMV-Tst-1 into U138-MG glial cells, which do not express Tst-1 (40) , and into HeLa cells along with the CAT constructs pJCV1 E Cat and p11.3.5E. The level of transactivation in U138-MG cells was ϳ5.1-fold for the full-length JCV (Mad1) promoter, pJCV1 E Cat, and ϳ7.1-fold for the JCV minimal core promoter, p11.3.5E (Fig. 5) , above the level observed when pCMV-Tst-1 was not cotransfected. In nonglial HeLa cells, the Tst-1 influence was less, with enhancement of pJCV1 E Cat of ϳ4.0-fold and of p11.3.5E of ϳ2.1-fold. These results indicate that sequences upstream from the core pro- type. Yet the Tst-1 enhancement of the core promoter in the absence of upstream elements was substantially greater in glial cells. This suggests that an additional glial cell-specific protein(s) that is not dependent upon cis elements upstream from the TATA is also required for maximum Tst-1 transactivation. Discrete affinity of Tst-1 for the JCV minimal core promoter is required for its glial cell specificity. From our observations that the level of transcription from the JCV minimal core promoter is sequence dependent and enhanced in the presence of Tst-1, we hypothesized that the level of transcriptional activity may correlate with Tst-1's affinity for the DNA sequence. To test this hypothesis, we examined the binding properties of Tst-1 to the wild-type JCV minimal core promoter and the various mutations which we created within this region in EMSAs. The oligonucleotides used for these studies are shown in Fig. 3 . The radioactive probe was the wild-type JCV minimal core promoter (Fig. 3, JCV TATA) . The source of the Tst-1 was a recombinant Gst-Tst-1 fusion protein, kindly provided by M. Rosenfeld. The EMSA shown in Fig. 6A reveals that the Gst-Tst-1 fusion protein readily binds the JCV core promoter in the absence of competitors. With increasing amounts of either the wild-type JCV sequence (JCV TATA) or the SV40 sequence (SV40 TATA) as the competitor, binding is diminished. To quantitate these results, the counts per minute (cpm) ratio of bound to total probe in the absence of competitors was defined as 100% maximal binding. By plotting the decline in percent maximal binding by the logarithm of the competitor concentration (Fig. 6C) , we could estimate a relative dissociation constant for Tst-1 with each competitor. The relative dissociation constants were estimated as the concentration of competitor required to reduce binding to 50% of maximal. With this analysis, quantitation of results from repeated experiments indicate that the JCV minimal core promoter has a relative dissociation constant for Tst-1 of ϳ1.41 ϫ 10 Ϫ8 M (Fig. 6C) . The relative dissociation constant for the analogous SV40 sequence is ϳ2.76 ϫ 10 Ϫ9 M (Fig. 6C) . Thus, Tst-1 has ϳ4.0-fold-greater affinity for the SV40 sequence than for the JCV sequence. This result was surprising in light of the transient-transfection studies, which showed that the SV40 sequence gave substantially less activity than the JCV core promoter. Previously, it was shown that a Tst-1 binding site (Fig. 6C, site B [40] ) with a relative affinity for Tst-1 approximately 2.5-fold less than that of the JCV core promoter sequence (Fig. 6C , JCV TATA and site A [40] ) was unable to drive expression of a heterologous promoter. Together with our results, this suggests that a cis element with an affinity for Tst-1 that is either substantially greater than (ϳ4.0-fold) or less than (ϳ2.5-fold) that of the JCV core promoter is not transactivated by Tst-1.
To further verify this, we extended the EMSA studies to include the JCV minimal core promoter mutant sequences that were previously observed to possess variable transcriptional activity in glial cells. The wild-type viral sequences are labeled JCV TATA and SV40 TATA and correspond to CAT constructs p11.3.5E and p11.3.8E (Fig. 3) , respectively. SV40-M1 TATA, -M2 TATA, and -M3 TATA correspond to CAT constructs p11.3.11E, p11.3.12E, and p11.3.13E, respectively, as shown in Fig. 3 . JCV-M1 TATA and JCV-M2 TATA correspond to CAT constructs p11.3.6E and p1.5E, respectively, as shown in Fig. 3 . AdML-inr represents the adenovirus major late initiator sequence, which was used as a nonspecific competitor. The sequence for AdML-inr is also shown in Fig. 3 .
The results of the EMSA with increasing amounts of the specified competitor are shown in Fig. 6A and B. The quantitation of results from repeated experiments is shown in Fig.  6C . From graphic representations of the data similar to that shown in Fig. 6C , we calculated the relative dissociation constant for each competitor duplex. For the competitors JCV TATA, JCV-M1 TATA, and JCV-M2 TATA, the relative dissociation constants are 1.41 ϫ 10 Ϫ8 M, 9.40 ϫ 10 Ϫ9 M, and 6.56 ϫ 10 Ϫ9 M, respectively. For the competitors SV40 TATA, SV40-M1 TATA, SV40-M2 TATA, and SV40-M3 TATA, the   FIG. 3 . Sequences of oligomers. The boldface uppercase letters represent JCV-derived sequence and site-specific mutants. The flanking nucleotides in lowercase letters correspond to vector sequence and were added for cloning purposes. All CAT constructs were synthesized by using the promoterless CAT expression vector pGK0Cat (20) . EMSA competitors were created by annealing the oligomers as shown.
relative dissociation constants are 2.76 ϫ 10 Ϫ9 M, 1.90 ϫ 10 Ϫ8 M, 8.33 ϫ 10 Ϫ9 M, and 3.35 ϫ 10 Ϫ9 M, respectively. To correlate the dissociation constant of each DNA duplex for Tst-1 with its ability to drive expression of the heterologous CAT reporter gene in glial cells, we plotted the relative promoter activity of each construct against its respective dissociation constant. Relative promoter activity was determined by CAT assay (Fig. 4B) . The compilation of these results is shown in Fig. 6D . From this curve, it appears that there is plasticity in the formation of a functional Tst-1-DNA complex. All the JCV sequences analyzed in these studies show a strong correlation between their affinity for Tst-1 and their ability to promote transcription of a reporter gene. When the affinity of a DNA sequence is greater than that observed for the wild-type JCV sequence (K dissociation ϭ 1.41 ϫ 10 Ϫ8 M), a less active complex results. Conversely, as suggested previously (40), a less active Tst-1-DNA complex may be formed when the affinity of a DNA sequence is substantially less (ϳ2.5-fold) than that observed for the wild-type JCV minimal core promoter sequence.
Tst-1 trans activation of JCV core promoter and mutants in HeLa cells correlates with their binding affinity for Tst-1. To further verify our observation that promoter activity is optimized for a discrete Tst-1 affinity, the expression plasmid pCMV-Tst-1 was cotransfected along with the JCV minimal core promoter mutants shown in Fig. 4A into nonglial HeLa cells. The percent increase in activity due to exogenous Tst-1 over that with the wild-type JCV minimal core promoter, p11.3.5E, was 124.9%. A similar level of transactivation, 147.6%, was also observed for the mutant construct p11.3.11E. The remaining mutant core promoter constructs were transactivated to the following extents: p11.3.6E, 118.5%; p11.3.12E, 108.0%; p1.5E, 107.2%, p11.3.13E, 0%; and p11.3.8E, 80.8%. These results are graphically represented in Fig. 6D . As the affinity for Tst-1 decreases from a dissociation constant of 2.8 ϫ 10
Ϫ9 M, associated with p11.3.8E and the wild-type SV40 core promoter, to 1.4 ϫ 10 Ϫ8 M, associated with p11.3.5E and the wild-type JCV core promoter, trans activation increases. This trend is similar to that observed with the same mutant promoters transfected into glial cells, also shown in Fig. 6D .
DISCUSSION
In this study, we have demonstrated that the portion of the regulatory region of JCV which we have termed the minimal core promoter is transcriptionally active in glial cells as an initiator without the aid of upstream cis elements. This region, from nt 1 to nt 28, is completely conserved among all JCV variants and contains a putative TATA box. This finding was surprising, since the TATA boxes of the majority of promoters are recognized by the basal transcription factor TFIID, a protein believed to be present in all cell types. During the course of these studies, however, the glial cell-specific transcriptional regulator Tst-1 was shown to bind the region of the JCV promoter surrounding the TATA box (40) . Here, we extend that observation to show that Tst-1, in conjunction with an additional adaptor protein(s), is intimately involved in directing glial cell-specific transcription from the JCV minimal core promoter. Furthermore, transactivation is dependent upon a discrete level of affinity of Tst-1 for its recognition site. Cell type-specific TATA region. Minimal core promoters, comprising TATA boxes and initiator elements, are usually required for basal transcription, with modulation and cell type specificity provided by upstream and downstream cis elements.
However, there are a few examples in which the minimal core promoter has been shown to confer cell type-specific expression to genes, both with and without the aid of upstream elements. Some of these include the canonical TATA core promoters of the genes for GHF-1 (27) , peripherin (8) , fibroin (38) , and myelin basic protein (37) .
Similar to other cell type-specific core promoters, the JCV core promoter contains a cell type-specific cis element in close Fig. 4 , are plotted against their corresponding dissociation constants for Tst-1, which were determined from data plotted as in C (left axis, solid circles). The same constructs were cotransfected into HeLa cells along with an equal amount of pCMV-Tst-1. Their percent increase in CAT activity due to Tst-1 cotransfection in HeLa cells is also plotted against their corresponding dissociation constants for Tst-1 (right axis, open circles).
proximity to those required for basal transcription. Overlapping the TATA region within the JCV core promoter is the recognition site for the cell type-specific transcriptional regulator Tst-1 (40) . For the GHF-1, peripherin, fibroin, and myelin basic protein gene core promoters, cell type-specific proteins also recognize sequence motifs centered around their TATA boxes (8, 27, 37, 38) . In contrast to other core promoters, the JCV core promoter appears to be active as an initiator. Transcription initiates from several locations within its sequence rather than ϳ30 bp downstream from the TATA box. The loss of tight control of transcription initiation of p11.3.5E compared with pJCV1 E Cat (Fig. 2) suggests that cis elements present upstream from the core promoter may be responsible for positioning transcription initiation 30 to 40 bp downstream from the TATA box.
Tighter control of transcription initiation was observed, however, in HJC cells. HJC cells are hamster glial cells transformed by genomic insertion of the gene for the JCV large T antigen. Transcription from both pJCV1 E Cat and p11.3.5E was initiated from a single site within the TATA region (data not shown). This start site corresponded with one identified previously and termed the prominent late-early, or L E0 , start site (18) . The L E0 site was associated with the presence of the viral large T antigen. It was noted that during the course of viral replication, after synthesis of the large T antigen, the prominent start site for early transcription shifted, from ϳ40 bp downstream from the center of the TATA box to a position within the TATA box itself (18) . Thus, while the JCV fulllength and truncated core promoters behave differently in the absence of the large T antigen, they are equally responsive to its modulation, suggesting that the T antigen may stabilize the transcription initiation complex over the TATA region.
Tst-1 directs transcription from the JCV minimal core promoter. Our transactivation studies suggest that Tst-1 is involved in controlling transcription from the JCV minimal core promoter (Fig. 5) . Because its cDNA was cloned independently three times, Tst-1 has also been called SCIP and Oct-6. The name SCIP reflects the observation that this protein is a suppressed cyclic AMP-inducible POU, which means that its level of expression is suppressed under conditions in which cyclic AMP levels are high (30) . The name Oct-6 indicates that Tst-1 is also a member of the family of octamer-binding proteins. The mRNA for Tst-1, as detected by Northern (RNA) blots, appears to be limited to the brain and testes (12) . Also, Tst-1 is expressed at different levels in various myelin-producing cells, specifically oligodendrocytes and Schwann cells, depending upon their stage of differentiation (12, 30) . The level of Tst-1 appears to be high when the cells are in a proliferative state and lower after the cells have differentiated.
Since JCV transcription is enhanced in glial cells, it seems reasonable that a protein found almost exclusively in glial cells is involved in regulating this process. Moreover, the role of Tst-1 within differentiated oligodendrocytes, although somewhat unclear, is to coordinate expression of myelin protein genes and repress genes associated with cell proliferation. In this way, it serves to maintain a homeostatic state that JCV can exploit to establish and maintain enhanced levels of transcription, which may lead to lytic viral replication and ultimately PML. In addition, it is intriguing that transcription from the JCV early promoter and subsequent expression of the oncogenic large T antigen is regulated by a protein that is intimately involved in cell proliferation. Transactivation of JCV early transcription by Tst-1, leading to elevated expression of the large T oncogene, may be an early step in tumorigenesis.
Glial cell-specific transcription from the JCV core promoter occurs through its discrete affinity for Tst-1. In this report, we have shown that Tst-1 exhibits a discrete affinity that is directly related to promoter strength (Fig. 6) . Mutants carrying mutations within the JCV minimal core promoter sequence that possess an affinity for Tst-1 which is substantially divergent from that of the wild-type JCV sequence show reduced transcriptional activity. This is true for mutations that result in a relatively high affinity for Tst-1 (K d , Ͻ1.4 ϫ 10 Ϫ8 M) and may also to be true for sequences exhibiting a relatively low level of affinity (K d , Ͼ4.9 ϫ 10 Ϫ8 M) as well. This correlation was observed in glial cells and is presumably mediated by endogenous Tst-1, since co-transfection of Tst-1 with the various JCV core promoter sequences in HeLa cells revealed a similar trend (Fig. 6D) . The plasticity with which Tst-1 binds to the JCV minimal core promoter may allow some yet unidentified glial cell protein(s) to interact with the JCV core promoter for optimum glial cell-specific transcription.
Our transactivation studies (Fig. 5 ) also suggest that an additional glial cell-specific protein(s) may be required for maximum Tst-1 transactivation. Furthermore, a cofactor protein(s) appears to be necessary for Tst-1 function in the absence of other proteins bound to upstream elements. Augmentation of Tst-1 function may be occurring either directly by proteins contacting Tst-1 or indirectly by proteins that interact with upstream elements. Additional cotransfection experiments or reconstitution in vitro transcription studies with additional JCV-associated transcription factors may clarify this point.
The hypothesis that, in addition to Tst-1, another cellular protein(s) is necessary to confer glial cell specificity on the JCV minimal core promoter is similar to the conclusions from the Lemke laboratory, where they have shown that repression of the P o promoter by Tst-1 may require a Schwann cell-specific adapter protein(s) in addition to Tst-1 binding (28) . For repression of the P o gene promoter, a specific, relatively high affinity Tst-1 binding site has not been linked to repressor function (28) . Moreover, it has been suggested that the interaction of Tst-1 with DNA may be less essential than its interactions with proteins that establish a more defined functional protein-DNA complex. In other words, the repressor activity of Tst-1, as well as other POU proteins, may not require specific DNA binding. However, when Tst-1 functions as a transactivator, specific binding sites have been identified and implicated in the establishment of a trans-activating Tst-1-DNA complex (29) . Thus, it seems logical to assume that the level of affinity of Tst-1 for specific sites within the DNA sequence is a determinant for trans-activation. This is in agreement with our observation that transactivation is dependent upon a discrete level of affinity of Tst-1 for the TATA region in the JCV minimal core promoter. Moreover, it establishes a mechanistic difference between the dual repressor and transactivator functions associated with this one protein. While the repressor function may not require specific binding sites within the DNA sequence, specific binding sites certainly appear to be required for the transactivator function.
The studies presented here reveal a new opportunity to investigate the interactions of cell type-specific trans-acting proteins with the basal transcriptional machinery. We are presently investigating the interactions of the TATA box-binding protein Tst-1 with the proteins of the basal transcription machinery.
